SLNO - SOLENO THERAPEUTICS INC

QQQ $ 445.88 $ 2.85 (0.64 %)

DIA $ 395.58 $ 1.12 (0.28 %)

SPY $ 523.16 $ 2.39 (0.46 %)

TLT $ 90.86 $ 0.51 (0.56 %)

GLD $ 218.12 $ 1.83 (0.85 %)

Previous Close

$ 43.5

Open

$ 43.22

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 43.22 - $ 44.24

52 Week Range

$ 3.69 - $ 53.82

Volume

219,419

Average Volume

Market Cap

1.58B

Beta (5Y Monthly)

$ 3.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-07-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	03-22-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-10-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	03-31-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	07-28-2021	06-30-2021	10-Q
13	05-05-2021	03-31-2021	10-Q
14	03-03-2021	12-31-2020	10-K
15	11-10-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-12-2020	03-31-2020	10-Q
18	03-04-2020	12-31-2019	10-K
19	11-13-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-13-2019	03-31-2019	10-Q
22	03-20-2019	12-31-2018	10-K
23	11-14-2018	09-30-2018	10-Q
24	08-14-2018	06-30-2018	10-Q
25	05-15-2018	03-31-2018	10-Q
26	04-02-2018	12-31-2017	10-K
27	11-14-2017	09-30-2017	10-Q
28	08-11-2017	06-30-2017	10-Q
29	05-11-2017	03-31-2017	10-Q
30	03-15-2017	12-31-2016	10-K
31	11-14-2016	09-30-2016	10-Q
32	08-12-2016	06-30-2016	10-Q
33	05-12-2016	03-31-2016	10-Q
34	03-25-2016	12-31-2015	10-K
35	11-12-2015	09-30-2015	10-Q
36	08-10-2015	06-30-2015	10-Q
37	05-04-2015	03-31-2015	10-Q
38	03-13-2015	12-31-2014	10-K
39	12-18-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Maintains Outperform on Soleno...
05/13/2024 12:36:24

Oppenheimer analyst Leland Gershell maintains Soleno Therapeutics (NASDAQ:SLNO) with a Outperform and lowers the price targe...

Baird Initiates Coverage On Soleno Therape...
05/10/2024 09:19:10

Baird analyst Brian Skorney initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Outperform rating and announces P...

Soleno Therapeutics Q1 2024 Adj EPS $(0.59...
05/09/2024 21:19:42

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of...

Reported Earlier, Soleno Therapeutics Pric...
05/03/2024 06:07:50

Soleno has also granted the underwriters a 30-day option to purchase up to 450,000 shares of common stock at the public offerin...

Soleno Therapeutics Announces Proposed Pub...
05/02/2024 20:41:22

Soleno Therapeutics, Inc. (NASDAQ:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical compan...

Soleno Therapeutics Announces Peer-Reviewe...
04/30/2024 12:15:19

Soleno Therapeutics, Inc. (Soleno) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for ...

us-stocks-kick-off-the-week-in-the-green-tesla-rockets-on-chinas-fsd-approval-yen-rallies-whats-driving-markets-monday

US Stocks Kick Off The Week In The Green, ...
04/29/2024 18:14:53

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events...

Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
04/29/2024 16:31:20

Tesla, Deciphera Pharmaceuticals, Heartlan...
04/29/2024 14:47:40

Soleno Therapeutics Receives Breakthrough ...
04/29/2024 12:02:15

First Ever Breakthrough Designation for a Drug Being Developed for PWSDesignation is Based on Data from the Phase 3 Program for...

Soleno Therapeutics Q4 EPS $(0.33) Misses ...
03/06/2024 21:24:12

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of...

Piper Sandler Initiates Coverage On Soleno...
02/05/2024 11:14:44

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Overweight rating and an...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
01/29/2024 21:31:25

Stifel Initiates Coverage On Soleno Therap...
01/23/2024 09:39:10

Stifel analyst Dae Gon Ha initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Buy rating and announces Price Targ...

Soleno Therapeutics Inc Files For Mixed Sh...
01/02/2024 22:05:21

- SEC Filing

Oppenheimer Maintains Outperform on Soleno...
01/02/2024 16:49:18

Oppenheimer analyst Leland Gershell maintains Soleno Therapeutics (NASDAQ:SLNO) with a Outperform and raises the price targe...

forget-the-magnificent-7-did-anyone-back-these-1000-gainers-in-2023

Forget The Magnificent 7: Did Anyone Back ...
12/28/2023 19:09:49

Baron Fifth Avenue Growth Fund gained nearly 60% over the year, while the Fidelity Blue Chip Growth ETF climbed 59%.

these-two-companies-surpass-nvidia-apple-and-microsoft-with-astounding-1000-returns-in-2023

These Two Companies Surpass Nvidia, Apple ...
12/28/2023 08:12:35

The two companies outperformed the 'Magnificent Seven' group of stocks, which includes tech giants such as Nvidia, Appl...

4 Analysts Have This to Say About Soleno T...
11/21/2023 18:00:42